A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

Clinical trial NCT01784211 · COMPLETED

Trial details

NCT number: NCT01784211
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2013-02-01
Primary completion: 2013-11-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.